BRPI0508768A - derivado de benzopirano da fórmula (i) ou (ii), ou sal farmaceuticamente aceitável do mesmo, medicamento e medicamento para o tratamento de arritmia - Google Patents

derivado de benzopirano da fórmula (i) ou (ii), ou sal farmaceuticamente aceitável do mesmo, medicamento e medicamento para o tratamento de arritmia

Info

Publication number
BRPI0508768A
BRPI0508768A BRPI0508768-6A BRPI0508768A BRPI0508768A BR PI0508768 A BRPI0508768 A BR PI0508768A BR PI0508768 A BRPI0508768 A BR PI0508768A BR PI0508768 A BRPI0508768 A BR PI0508768A
Authority
BR
Brazil
Prior art keywords
group
medicament
hydrogen atom
ring
atom
Prior art date
Application number
BRPI0508768-6A
Other languages
English (en)
Inventor
Kazuhiko Ohrai
Yukihiro Shigeta
Osamu Uesugi
Tomoyuki Matsuda
Takumi Okada
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of BRPI0508768A publication Critical patent/BRPI0508768A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D515/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D515/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Dental Preparations (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"DERIVADO DE BENZOPIRANO DA FóRMULA (I) OU (II), OU SAL FARMACEUTICAMENTE ACEITáVEL DO MESMO, MEDICAMENTO E MEDICAMENTO PARA O TRATAMENTO DE ARRITMIA". Esta invenção refere-se a derivados de benzopirano da fórmula (I) ou (II), ou sais farmaceuticamente aceitável do mesmo, em que R¬ 1¬ e R¬ 2¬ são independentemente um do outro átomo hidrogênio, grupo alquil C~ 1-6~ ou grupo aril C~ 6-14~, R¬ 3¬ é átomo hidrogênio ou grupo alquilcarboniloxi C~ 1-6~, ou junto com R¬ 4¬ forma um aglutinante, R¬ 4¬ é átomo hidrogênio, ou junto com R¬ 3¬ forma um aglutinante, m é um número inteiro de 0 a 4, n é um número inteiro de 0 a 4, V é um aglutinante único, CR¬ 7¬R¬ 8¬, NR¬ 9¬, O, S, SO OU SO~ 2~, R¬ 5¬ é átomo hidrogênio ou grupo alquil C~ 1-6~, R¬ 6¬ é atomo hidrogênio, grupo alquil C~ 1-6~, grupo cicloalquil C~ 3-8~, grupo cicloalquenil C~ 3-8~, grupo amina, grupo alquilamina C~ 1-6~, grupo alquilamina di-C~ 1-6~, grupo arilamina C~ 6-14~, grupo heteroarilamina C~ 2-9~, grupo aril C~ 6-14~, grupo heteroaril C~ 2-9~ ou grupo heterociclil C~ 2-9~, A é anel membro derretido 5-, 6- ou 7-com anel benzeno, como átomo constituinte do anel, átomo oxigênio, átomo nitrogênio ou átomo enxofre pode estar contido no número de 1 a 3 sozinho ou em uma combinação do mesmo, o número de aglutinante insaturados do anel é 1, 2 ou 3 incluindo como aglutinante insaturado do anel benzeno para ser derretido, átomo carbonos constituindo o anel pode ser carbonil ou tiocarbonil. Estes compostos são eficazes como um agente anti-arrítmico.
BRPI0508768-6A 2004-03-23 2005-03-23 derivado de benzopirano da fórmula (i) ou (ii), ou sal farmaceuticamente aceitável do mesmo, medicamento e medicamento para o tratamento de arritmia BRPI0508768A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004084605 2004-03-23
PCT/JP2005/006004 WO2005090357A1 (en) 2004-03-23 2005-03-23 Tricyclic benzopyran compound as anti-arrhythmic agents

Publications (1)

Publication Number Publication Date
BRPI0508768A true BRPI0508768A (pt) 2007-02-27

Family

ID=34962589

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0508768-6A BRPI0508768A (pt) 2004-03-23 2005-03-23 derivado de benzopirano da fórmula (i) ou (ii), ou sal farmaceuticamente aceitável do mesmo, medicamento e medicamento para o tratamento de arritmia

Country Status (31)

Country Link
US (2) US7652008B2 (pt)
EP (1) EP1732929B1 (pt)
JP (1) JP4840594B2 (pt)
KR (2) KR101085979B1 (pt)
CN (3) CN102190661B (pt)
AT (1) ATE485299T1 (pt)
AU (2) AU2005223612B2 (pt)
BR (1) BRPI0508768A (pt)
CA (1) CA2558139C (pt)
CY (1) CY1111250T1 (pt)
CZ (1) CZ2006598A3 (pt)
DE (1) DE602005024245D1 (pt)
DK (1) DK1732929T3 (pt)
EG (1) EG27163A (pt)
ES (1) ES2353021T3 (pt)
HK (1) HK1099299A1 (pt)
HR (1) HRP20110005T1 (pt)
IL (1) IL177950A (pt)
MX (1) MXPA06010880A (pt)
NO (1) NO339495B1 (pt)
NZ (2) NZ585606A (pt)
PL (1) PL1732929T3 (pt)
PT (1) PT1732929E (pt)
RS (1) RS51742B (pt)
RU (1) RU2380370C2 (pt)
SI (1) SI1732929T1 (pt)
SK (1) SK287994B6 (pt)
TW (1) TWI352704B (pt)
UA (1) UA91189C2 (pt)
WO (1) WO2005090357A1 (pt)
ZA (1) ZA200607388B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ585606A (en) * 2004-03-23 2011-11-25 Nissan Chemical Ind Ltd Tricyclic benzopyran compound as anti-arrhythmic agents
AU2007225765B2 (en) 2006-03-10 2012-05-24 Nissan Chemical Industries, Ltd. Process for producing optically active chromene oxide compound
WO2010018867A1 (ja) * 2008-08-14 2010-02-18 日産化学工業株式会社 ジ置換ベンゾピラン化合物
BRPI1007112A2 (pt) * 2009-04-30 2015-08-18 Nissan Chemical Ind Ltd Formas cristalinas a,b,e,f,g e h compostos triciclicos benzopirano e metodo para produçao das mesmas
PL2445502T5 (pl) 2009-06-25 2023-03-13 Alkermes Pharma Ireland Limited Związki heterocykliczne do leczenia zaburzeń neurologicznych i psychologicznych
JPWO2014051077A1 (ja) * 2012-09-27 2016-08-25 日産化学工業株式会社 高純度の含窒素複素環化合物の製造方法
CN104507948B (zh) * 2012-09-27 2017-05-03 日产化学工业株式会社 含氮杂环n‑氧化物化合物的制造方法
CN105377826A (zh) * 2013-07-25 2016-03-02 日产化学工业株式会社 杂环化合物的制造方法
CN110177796B (zh) * 2017-01-06 2022-04-08 阿斯克里斯有限公司 喹啉酮衍生物及其用于预防或治疗变应性疾病的药物组合物
CA3092335A1 (en) 2018-03-05 2019-09-12 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy
CN108727261B (zh) * 2018-06-21 2021-09-24 济南大学 一种硝基取代喹那啶的制备方法
EP3903882A4 (en) * 2018-12-28 2022-09-21 Osaka University THERAPEUTIC AGENT FOR INHERITED BRADYARRHYTHMIA
RU2754610C1 (ru) * 2020-04-14 2021-09-03 Георгий Викторович ТЕЦ Препарат для лечения заболеваний, вызванных бактериями
JPWO2021261598A1 (pt) * 2020-06-26 2021-12-30

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZM7682A1 (en) 1981-09-25 1983-05-23 Beecham Group Plc Active compounds
JPS5867683U (ja) 1981-10-28 1983-05-09 株式会社ナムコ 歩行ロボツト
JPH0699439B2 (ja) 1988-02-03 1994-12-07 日産化学工業株式会社 ピラノベンゾオキサジアゾール誘導体
JP2658198B2 (ja) 1988-06-23 1997-09-30 日産化学工業株式会社 ピラノベンゾトリアゾール誘導体
JP2876712B2 (ja) * 1989-07-17 1999-03-31 日産化学工業株式会社 光学活性ピラノベンゾオキサジアゾール誘導体
US5097037A (en) * 1989-07-17 1992-03-17 Nissan Chemical Industries, Ltd. Process for the optical resolution of pyranobenzoxadiazole compounds
US5164509A (en) * 1990-11-26 1992-11-17 E. R. Squibb & Sons, Inc. Benzodiazolo analogs
JPH07300414A (ja) * 1993-04-02 1995-11-14 Nissan Chem Ind Ltd 心不全治療薬
KR960700713A (ko) 1993-04-02 1996-02-24 도쿠시마 슈이치 심부전증 치료약(medicines for cardiac insufficiency)
JP2734457B2 (ja) 1994-02-23 1998-03-30 日産化学工業株式会社 不斉エポキシ化反応
US5843989A (en) 1994-06-10 1998-12-01 Smithkline Beecham P.L.C. C4 -amide substituted compounds and their use as therapeutic agents
ES2218617T3 (es) * 1996-05-15 2004-11-16 Aventis Pharma Deutschland Gmbh Cromanos sustituidos con sulfonamida, procedimiento para su preparacion, su uso como medicamento o agente de diagnostico, asi como medicamentos que los contienen.
DE69921815T2 (de) 1998-06-03 2005-11-10 Nissan Chemical Industries, Ltd. Indanderivate
AU5444499A (en) 1998-09-01 2000-03-21 Nissan Chemical Industries Ltd. Benzoxazine derivatives
AU2830800A (en) 1999-03-25 2000-10-16 Nissan Chemical Industries Ltd. Chroman derivatives
EP1212314B1 (en) 1999-09-17 2005-11-30 Nissan Chemical Industries, Ltd. Benzopyran derivative
US6555574B1 (en) 1999-09-24 2003-04-29 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
EP1218367A1 (en) 1999-10-05 2002-07-03 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
TW589305B (en) 2001-02-14 2004-06-01 Nissan Chemical Ind Ltd 4-aminobenzopyran derivatives
DE60206505T2 (de) 2001-06-25 2006-07-06 Nissan Chemical Industries, Ltd. Substituierte benzopyranderivate gegen arrhytmie
WO2003014113A1 (en) 2001-08-06 2003-02-20 Glenmark Pharmaceuticals Limited Novel benzopyran compounds and process for their preparation and use
NZ585606A (en) * 2004-03-23 2011-11-25 Nissan Chemical Ind Ltd Tricyclic benzopyran compound as anti-arrhythmic agents

Also Published As

Publication number Publication date
PL1732929T3 (pl) 2011-04-29
UA91189C2 (en) 2010-07-12
CN101429200A (zh) 2009-05-13
MXPA06010880A (es) 2006-12-15
HK1099299A1 (en) 2007-08-10
IL177950A0 (en) 2006-12-31
SK287994B6 (sk) 2012-09-03
KR20070009638A (ko) 2007-01-18
JP4840594B2 (ja) 2011-12-21
US7964623B2 (en) 2011-06-21
SK50792006A3 (sk) 2007-09-06
AU2010202900A1 (en) 2010-07-29
EG27163A (en) 2015-08-24
CY1111250T1 (el) 2015-06-11
HRP20110005T1 (hr) 2011-02-28
US20100069374A1 (en) 2010-03-18
CN1934116B (zh) 2012-10-10
RS51742B (en) 2011-10-31
EP1732929B1 (en) 2010-10-20
NZ549570A (en) 2010-08-27
CA2558139A1 (en) 2005-09-29
TW200600509A (en) 2006-01-01
NZ585606A (en) 2011-11-25
CN102190661B (zh) 2013-07-31
KR101019402B1 (ko) 2011-03-07
KR20100130249A (ko) 2010-12-10
NO20064819L (no) 2006-10-23
JP2007530436A (ja) 2007-11-01
RU2006137284A (ru) 2008-04-27
RU2380370C2 (ru) 2010-01-27
AU2010202900B2 (en) 2011-10-27
NO339495B1 (no) 2016-12-19
TWI352704B (en) 2011-11-21
CN1934116A (zh) 2007-03-21
AU2005223612A1 (en) 2005-09-29
CN101429200B (zh) 2012-05-30
CZ2006598A3 (cs) 2006-11-15
ZA200607388B (en) 2008-07-30
CN102190661A (zh) 2011-09-21
WO2005090357A1 (en) 2005-09-29
AU2005223612B2 (en) 2010-06-24
ATE485299T1 (de) 2010-11-15
US20080004262A1 (en) 2008-01-03
KR101085979B1 (ko) 2011-11-22
CA2558139C (en) 2012-01-17
IL177950A (en) 2013-04-30
US7652008B2 (en) 2010-01-26
ES2353021T3 (es) 2011-02-24
PT1732929E (pt) 2010-12-21
DE602005024245D1 (de) 2010-12-02
EP1732929A1 (en) 2006-12-20
DK1732929T3 (da) 2010-12-20
SI1732929T1 (sl) 2010-12-31

Similar Documents

Publication Publication Date Title
BRPI0508768A (pt) derivado de benzopirano da fórmula (i) ou (ii), ou sal farmaceuticamente aceitável do mesmo, medicamento e medicamento para o tratamento de arritmia
MX9504287A (es) Derivados de camptotecina y proceso para su preparacion.
WO2006055747A3 (en) Bis(thio-hydrazide amides) for increasing hsp70 expression
RS107504A (en) Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compostions including the same, and methods for their use
ATE416176T1 (de) Kondensierte chinolinderivate und deren anwendung
AP2003002841A0 (en) Quinazolines as MMP-13 inhibitors
PT1029853E (pt) Derivados biciclicos heteroaromaticos uteis como agentes anticancerigenos
TW200507839A (en) Therapeutic agents
HUP0002843A2 (hu) Új béta-karbolin-származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
RS20060190A (en) Bicyclic /3.1.0/ derivatives as glycine transporter inhibitors
TW200510418A (en) Substituted 8'-pyridinyl-dihydrospiro-[cycloalkyl]-pyrimido [1, 2-a] pyrimidin-6-one and 8'-pyrimidinyl-dihydrospiro-[cycloalkyl]-pyrimido [1, 2-a] pyrimidin-6-one derivatives
ATE260252T1 (de) Thiocolchicin-derivate mit entzündungshemmender und muskelrelaxierender wirkung
GEP20115240B (en) Indole derivatives, process for their preparation and pharmaceutical compositions containing them
MXPA01013148A (es) Nuevos derivados de amonio cuaternario, metodo para la preparacion de los mismos y uso farmaceutico.
AR035375A1 (es) Compuesto derivado de pirrol sustituido, composicion farmaceutica y su uso en la fabricacion de un medicamento para inhibir la farnesiltransferasa
ATE402179T1 (de) Indolderivate und deren verwendung in medikamenten
AR010650A1 (es) COMPUESTO DERIVADO DE CEFEm, COMPOSICION FARMACEUTICA QUE LO CONTIENE Y USO DEL MISMO
DE69319939D1 (de) Aminobenzoesäure Derivate
ATE259641T1 (de) Amidderivate
TH77892B (th) อนุพันธ์เบนซ์ออกซาซีพีน
TH61861A3 (th) 4-ออกโซ-1,4-ไดไฮโดร-3-ควิโนลีนคาร์บอกซามีดที่เป็นตัวกระทำต้านเชื้อไวรัส
ECSP992984A (es) Derivados de isotiazol utiles como agentes anticancerosos
TH74460A (th) อนุพันธ์ของ 8'-พิริ(มิ)ดินิล-ไดไฮโดรสไปโร-[ไซโคลอัลคิลามีน]-พิริมิโด[1,2-a]พิริมิดิน-6-โอน ที่ถูกแทนที่
TH77892A (th) อนุพันธ์เบนซ์ออกซาซีพีน

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements